CIK 0001200375 · Non-accelerated filer<br>Smaller reporting company
CODEXIS, INC.
Sign in to watch- Ticker
- CDXS
- Exchange
- Nasdaq
- Industry
- Industrial Organic Chemicals
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 710872999
- Phone
- 650-421-8100
- Business address
- 200 PENOBSCOT DRIVE, REDWOOD CITY, CA, 94063
- Former names
- CODEXIS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $18,446
- in 3 filings
Net −$18,446. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 61 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-03-22 | NICOLS JOHN J President and CEO | Sale | −6,311 | $11.91 | $75K | 1,072,679 |
| 2018-03-22 | NICOLS JOHN J President and CEO | Option exercise · Stock Option (Right to Buy) | +6,311 | 393,689 | ||
| 2018-03-21 | KELLEY BERNARD J Director | Sale | +10,206 | $12.22 | $125K | 229,951 |
| 2018-03-05 | SANGSTER GORDON SVP & Chief Financial Officer | Shares withheld for taxes | −18,497 | $10.90 | $202K | 171,925 |
| 2018-03-05 | NICOLS JOHN J President and CEO | Shares withheld for taxes | −92,175 | $10.90 | $1.0M | 1,072,679 |
| 2018-03-05 | Lalonde James SVP, R&D | Shares withheld for taxes | −11,920 | $10.90 | $130K | 230,066 |
| 2018-02-21 | Aldridge Michael D. See Remarks | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2018-02-21 | Lalonde James SVP, R&D | Grant or award · Stock Option (Right to Buy) | +55,000 | 55,000 | ||
| 2018-02-21 | NICOLS JOHN J President and CEO | Grant or award · Stock Option (Right to Buy) | +130,000 | 130,000 | ||
| 2018-02-21 | SANGSTER GORDON SVP & Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2018-02-20 | SANGSTER GORDON SVP & Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2018-02-20 | NICOLS JOHN J President and CEO | Grant or award · Stock Option (Right to Buy) | +130,000 | 130,000 | ||
| 2018-02-20 | Lalonde James SVP, R&D | Grant or award · Stock Option (Right to Buy) | +55,000 | 55,000 | ||
| 2018-02-20 | Aldridge Michael D. See Remarks | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2018-02-05 | SANGSTER GORDON SVP & Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +167,750 | 167,750 | ||
| 2018-02-05 | Aldridge Michael D. See Remarks | Grant or award · Stock Option (Right to Buy) | +167,750 | 167,750 | ||
| 2018-02-05 | Lalonde James SVP, R&D | Grant or award · Stock Option (Right to Buy) | +147,620 | 147,620 | ||
| 2018-02-05 | NICOLS JOHN J President and CEO | Grant or award · Stock Option (Right to Buy) | +671,000 | 671,000 | ||
| 2017-09-14 | Vivo Ventures Fund VII, L.P. 10% owner | Sale | −1,037,390 | $5.78 | $6.0M | 4,144,495 |
| 2017-09-14 | Vivo Ventures Fund VII, L.P. 10% owner | Sale | −22,610 | $5.78 | $131K | 90,330 |
Page 27 of 36 · 712 trades